Tirzepatide for severe cannabis use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests if tirzepatide, a hormone-like medicine, can help people with severe cannabis use disorder reduce their cannabis use. It may work by changing how your body responds to certain signals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and speak English
- You must have a severe cannabis use disorder as diagnosed by a doctor
- You cannot have a current or past eating disorder like anorexia or bulimia
- You cannot have diabetes or a history of certain thyroid or pancreas problems
- You cannot be taking weight loss drugs or similar medications like Ozempic
- You must not be pregnant, breastfeeding, or have other severe health conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tirzepatide (a medication that affects appetite and metabolism) can help people reduce or stop cannabis use. It is for adults who want treatment for cannabis use disorder.
This trial tests whether a medication called semaglutide (used for weight management) can help adults with cannabis use disorder cut down or stop using cannabis. Researchers want to see if it reduces cravings and use while also monitoring overall health.
This study tests whether a medication called tirzepatide (originally developed for diabetes) can help people reduce or stop cannabis use. It is for adults who use cannabis frequently and are motivated to seek treatment.
This trial tests if tirzepatide, a medication that helps with appetite and blood sugar, can help people with alcohol use disorder drink less or stop drinking. You would visit the clinic regularly and receive the drug or a placebo.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This trial tests whether a weekly injection called tirzepatide (a diabetes and weight-loss medication) can help people with obesity and stimulant use disorder reduce stimulant use and lose weight. It aims to see if treating both conditions together improves outcomes.
Hear when a new Cannabis Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.